Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy
- PMID: 38185867
- DOI: 10.4103/ijc.ijc_19_23
Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy
References
-
- Nirvani M, Khuu C, Utheim TP, Sand LP, Sehic A. Circadian clock and oral cancer. Mol Clin Oncol 2018; 8:219–26
-
- Gong X, Tang H, Yang K. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex. Cell Death Dis 2021; 12:276
-
- Giacchetti S, Bjarnason G, Garufi C, Genet D, Iacobelli S, Tampellini M, et al. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group. J Clin Oncol 2006; 24:3562–9
-
- Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol Int 2002; 19:237–51
-
- Zhou J, Wang J, Zhang X, Tang Q. New insights into cancer chronotherapies. Front Pharmacol 2021; 12:741295. doi: 10.3389/fphar.2021.741295 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
